FDA Inspection 1305670 — Upsher-Smith Laboratories, LLC
The FDA completed an inspection of Upsher-Smith Laboratories, LLC on Feb 10, 2026 in Maple Grove, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 10, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Maple Grove, MN (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)